A highly sensitive and specific indirect competitive enzyme-linked immunosorbent assay (ELISA) for the determination of diclofenac in water samples was developed. With pure water, the limit of detection (LOD, S/N = 3) and IC50 were found to be 6 ng/L and 60 ng/L, respectively. The analytical working range was about 20-400 ng/L. Highest cross-reactivity (CR) of 26 tested pharmaceuticals, metabolites, and pesticides was found for 5-hydroxydiclofenac (100%). Other estimated values were well below 4% and, therefore, are negligible. The assay was applied for the determination of diclofenac in tap and surface water samples as well as wastewater collected at 20 sewage treatment plants (STPs) in Austria and Germany. Humic substances were identified as main interference in surface water. Wastewater samples which were only submitted to filtration and dilution yielded about 25% higher diclofenac concentrations using the ELISA compared to GC-MS. However, the ELISA turned out to be a simple, inexpensive, and accurate method for the determination of diclofenac both in influent and effluent wastewater after rather simple sample preparation, i.e., filtration, acidification, and readjustment to neutral pH-value, and at least 10-fold dilution with pure water.
We report on the synthesis and properties of 6,6′-dithienylindigo (DTI) and poly(DTI). Redox chemistry and ambipolar charge transport with μh = 0.11 cm2 V−1 s−1 and μe = 0.08 cm2 V−1 s−1 and excellent air stability are shown.
A method for the quantitative determination of seven major antidepressants in surface waters and sewage treatment plant effluents by CE using ESI-MS is presented. Calibration curves for the selected analytes were prepared in Milli-Q purified water and Danube river water extract covering a concentration range of at least one order of magnitude. LODs achieved were between 6 and 13 microg/L for Trazodone and 39 and 53 microg/L for Sertraline in the Milli-Q purified water and Danube river water matrix, respectively. For sample preparation eight different SPE materials were investigated. Best results were obtained for a resin based on hydrophilic divinylbenzene (recoveries from Milli-Q purified water 93-96%; from Danube river water 85-99%). Finally, a series of eight sewage treatment plant effluents were investigated with respect to their content in the selected antidepressants. Six of these samples were tested positive for antidepressants, in particular Venlafaxine, Citalopram and Trazodone in concentrations between 36 and 322 ng/L.
A 2,2′-bipyridyl-containing
poly(arylene-ethynylene)-alt-poly(arylene-vinylene)
polymer, acting as a light-harvesting
ligand system, was synthesized and coupled to an organometallic rhodium
complex designed for photocatalytic NAD+/NADH reduction.
The material, which absorbs over a wide spectral range, was characterized
by using various analytical techniques, confirming its chemical structure
and properties. The dielectric function of the material was determined
from spectroscopic ellipsometry measurements. Photocatalytic reduction
of nucleotide redox cofactors under visible light irradiation (390–650
nm) was performed and is discussed in detail. The new metal-containing
polymer can be used to cover large surface areas (e.g. glass beads)
and, due to this immobilization step, can be easily separated from
the reaction solution after photolysis. Because of its high stability,
the polymer-based catalyst system can be repeatedly used under different
reaction conditions for (photo)chemical reduction of NAD+. With this concept, enzymatic, photo-biocatalytic systems for solar
energy conversion can be facilitated, and the precious metal catalyst
can be recycled.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.